Nukkleus INC. 8-K Filing
Ticker: DFNSW · Form: 8-K · Filed: Nov 28, 2025 · CIK: 1787518
Sentiment: neutral
Filing Stats: 759 words · 3 min read · ~3 pages · Grade level 11.5 · Accepted 2025-11-28 13:05:35
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share NUKK The Nasdaq
- $92.00 — sable for one Share of Common Stock for $92.00 per share NUKKW The Nasdaq Stock Ma
- $10.00 — Units were sold at an offering price of $10.00 per Unit, generating gross proceeds to
- $172,500,000 — ross proceeds to SC II of approximately $172,500,000. Each Unit consists of one Class A ordi
Filing Documents
- ea0267549-8k_nukkleus.htm (8-K) — 31KB
- ea026754901ex99-1_nukkleus.htm (EX-99.1) — 11KB
- 0001213900-25-115927.txt ( ) — 253KB
- nukk-20251128.xsd (EX-101.SCH) — 4KB
- nukk-20251128_def.xml (EX-101.DEF) — 26KB
- nukk-20251128_lab.xml (EX-101.LAB) — 36KB
- nukk-20251128_pre.xml (EX-101.PRE) — 25KB
- ea0267549-8k_nukkleus_htm.xml (XML) — 6KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On November 28, 2025, Nukkleus Inc. (the "Company") issued a press release announcing the closing of the initial public offering (the "IPO") of SC II Acquisition Corp. ("SC II"), a newly formed special purpose acquisition company and indirect subsidiary of the Company. A copy of the Company's press release dated November 28, 2025 relating to the closing of SC II's IPO is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information contained in Exhibit 99.1 hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as expressly set forth by specific reference in such a filing.
01 Other Events
Item 8.01 Other Events. On November 28, 2025, SC II closed its IPO of 17,250,000 units (the "Units"), including exercise in full by the underwriters of an option to purchase up to an additional 2,250,000 Units. The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds to SC II of approximately $172,500,000. Each Unit consists of one Class A ordinary share of SC II, par value $0.0001 per share (the "Class A Ordinary Shares"), and one right to receive one-fifth (1/5) of one Class A Ordinary Share upon the consummation of SC II's initial business combination (each, a "Share Right"). SC Capital II Sponsor LLC, a Delaware limited liability company and indirect subsidiary of the Company (the "Sponsor"), in which the Company holds a majority interest, is acting as the sponsor of SC II. Simultaneously with the closing of the IPO, pursuant to a Sponsor Private Placement Units Purchase Agreement, dated November 25, 2025, by and between SC II and the Sponsor, the Sponsor acquired 255,000 Units (the "Sponsor Units") at a price of $10.00 per Sponsor Unit. The issuance of the Sponsor Units was made pursuant to an exemption from registration contained in Section 4(a)(2) of the Securities Act.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release of Nukkleus Inc. dated November 28, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NUKKLEUS INC. Date: November 28, 2025 By: /s/ Menachem Shalom Name: Menachem Shalom Title: Chief Executive Officer 2